Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT-Reference-Cited by-同舟云学术

Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

Published:2023-08-29 Issue:10 Volume:39 Page:1395-1405
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Stolz Daiana¹,Hermansson Erik²,Ouwens Mario²,Singh Barinder³,Sharma Akanksha³,Jackson Dan⁴,Darken Patrick⁵,Marshall Jonathan⁴,Bowen Karin⁵,Müllerová Hana⁴,Alcázar Navarrete Bernardino⁶⁷,Russell Richard⁸,Han MeiLan K.⁹,Tansey-Dwyer Deniz⁴

Affiliation:

1. Clinic of Respiratory Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany

2. AstraZeneca, Gothenburg, Sweden

3. Pharmacoevidence, Mohali, India

4. AstraZeneca, Cambridge, UK

5. AstraZeneca, Gaithersburg, MD, USA

6. Respiratory Department, Hospital Universitario Virgen de las Nieves, Granada, Spain

7. Instituto Biosanitario de Granada, IBS-Granada, Granada, Spain

8. King’s Centre for Lung Health, Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK

9. Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, MI, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2023.2247969

Reference51 articles.

1. Global Initiative for Chronic Obstructive Lung Disease. 2023 GOLD Report. Global strategy for prevention diagnosis and management of COPD [Internet]. 2023 [cited November 20 2022]. Available from: https://goldcopd.org/2023-gold-report-2/.

2. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019

3. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

4. Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease

5. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeled small airways lung deposition of two fixed-dose triple therapy combinations assessed with in silico functional respiratory imaging;Respiratory Research;2023-09-23